Keynote Speakers

Prof Okezie Aruoma

President and Chief Executive Officer

Global PharmHealth Investors Inc.
Strategic planning and operational aspects of policies, objectives, and initiatives to enhance sustainability, profitability and growth of the organization, with experiences bench-marked on training in business administration and leadership in academia, research scholarship and entrepreneurship. Emphasis include development of global education, global pharmacy and pharmaceutical drug development, global health initiatives, pharmacogenomics in the age management of wellness strategically addressing nutrition, patient centered therapeutics and drug delivery to minimize adverse drug reactions and improve compliance in therapy. Competencies extend to exploring opportunities to support new business enterprises as part of the entrepreneurial portfolio at Global PharmHealth Investors Inc. (www.globalpharmhealthinvestors.org)Strategic planning and operational aspects of policies, objectives, and initiatives to enhance sustainability, profitability and growth of the organization, with experiences bench-marked on training in business administration and leadership in academia, research scholarship and entrepreneurship. Emphasis include development of global education, global pharmacy and pharmaceutical drug development, global health initiatives, pharmacogenomics in the age management of wellness strategically addressing nutrition, patient centered therapeutics and drug delivery to minimize adverse drug reactions and improve compliance in therapy. Competencies extend to exploring opportunities to support new business enterprises as part of the entrepreneurial portfolio at Global PharmHealth Investors Inc. (www.globalpharmhealthinvestors.org)

Prof David M. DeMarini

David DeMarini began his current position as a Genetic Toxicologist at the US Environmental Protection Agency (US EPA), Research Triangle Park, NC in 1985. Before that he received his B.S. (1972), M.S. (1974), and Ph.D. (1980) in Biological Sciences (genetics) at Illinois State University, Normal, IL, studying under Dr. Herman E. Brockman. From 1980-1982, he did postdoctoral research at the Biology Division, Oak Ridge National Laboratory, Oak Ridge, TN. He then was a Research Geneticist at the National Toxicology Program, National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, NC from 1983-1984. Dr. DeMarini is also an Adjunct Professor, Dept. of Environ. Sci. & Engineering, School of Public Health, University of North Carolina, Chapel Hill, NC (1991-present). He is a member of the Environmental Mutagenesis and Genomics Society (EMGS) and the Genetics and Environmental Mutagenesis Society (GEMS). He has served as President of EMGS, GEMS, and of the International Association of Environmental Mutagen Societies. He is an Editor of Mutation Research–Reviews (1998-present) and is on the Editorial Board of Environmental and Molecular Mutagenesis (1984-1989, 1993-present) and Genes and Environment (2006-present). He has organized conferences, symposia, and training courses internationally, and has given invited lectures at more than 130 conferences in 55 countries. He has served on both (1986 and 2004) Tobacco Smoking and Cancer Monographs of the International Association for Research on Cancer (IARC) with WHO in Lyon, France, as well as the IARC Monographs on Drinking Water/Arsenic, Indoor Air, Human Carcinogens, Auto and Diesel Exhaust, and Indoor and Outdoor Air. He Chaired the IARC Monograph on Drinking Water, Food, and Industrial Chemicals (2011). He has published more than 170 articles and received the Alexander Hollaender Award from the EMGS in 2011. He has mentored 20 graduate students and postdocs through his adjunct professorship at UNC-Chapel Hill. His research interests are:

  • molecular mechanisms of mutagenesis
  • mutation spectra
  • complex mixtures
  • and biomarkers of mutation in humans